SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-029039
Filing Date
2021-04-29
Accepted
2021-04-29 17:30:07
Documents
2
Period of Report
2021-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10469
2 POA DOCUMENT poa.txt EX-24.3_981506 4232
  Complete submission text file 0001209191-21-029039.txt   16108
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH STREET BOSTON MA 02116
Business Address
EVNIN LUKE (Reporting) CIK: 0001134657 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40366 | Film No.: 21872317

Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations